HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ependymoblastoma associated with prenatal exposure to diphenylhydantoin and methylphenobarbitone.

Abstract
Ependymoblastoma developed in a 28-month-old girl whose epileptic mother took diphenylhydantoin and methylphenobarbitone throughout pregnancy. The child was also shown to be a genetic carrier for ornithine transcarbamylase deficiency, an x-linked inborn error of urea cycle metabolism. The possibility of transplacental carcinogenesis should be considered, as other juvenile embryonic tumors such as neuroblastoma, melanotic neuroectodermal tumor, and mesenchymoma have been reported in offspring after diphenylhydantoin use by the mother during pregnancy.
AuthorsA Lipson, P Bale
JournalCancer (Cancer) Vol. 55 Issue 9 Pg. 1859-62 (May 01 1985) ISSN: 0008-543X [Print] United States
PMID3978571 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Mephobarbital
  • Phenytoin
Topics
  • Brain Neoplasms (chemically induced)
  • Child, Preschool
  • Ependymoma (chemically induced)
  • Female
  • Frontal Lobe
  • Heterozygote
  • Humans
  • Maternal-Fetal Exchange
  • Mephobarbital (adverse effects)
  • Ornithine Carbamoyltransferase Deficiency Disease
  • Phenytoin (adverse effects)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: